Business

Subcategories:
Biotechnology Consumerism/Marketing Gambling Lobbying/Contracting	Oil Pharmaceuticals Big Tobacco Main Category List

---

Culture Change
Does the Selling of Stonyfield Farm Yogurt Signal the End of Socially Responsible Businesses -- Or a New Beginning?
By David Goodman
January/February 2003 Issue

Why is This Man Laughing?
January/February 1998 Issue

The Microsoft Network
Bill insists he wants to avoid politics. Meanwhile, he's waged a quietly massive attack on the other Washington. Plus: Washington Wide Web: Microsoft's lobbyists and their power ties.
By Ken Silverstein
January/February 1998 Issue

Washington Wide Web
Microsoft's 1995-1997 lobbyists and their power ties.
By Ken Silverstein
January/February 1998 Issue

Overseas Invasion
Like Coke, Nike, and the tobacco industry before it, Microsoft now has to hook new consumers abroad. But the company has discovered a way to bully foreign companies into buying Microsoft -- and only Microsoft.
By Rachel Burstein
January/February 1998 Issue

His Way
Bill says Microsoft just wants to make good software. So how will it end up owning Sinatra tunes?
By G. Pascal Zachary
January/February 1998 Issue

Lock Your Windows
Microsoft says it's spying on you with only the purest of intentions. At least for now...
By Richard Blow
January/February 1998 Issue

Sleight of Hand
Microsoft is trying to make you forget about it's nerdy CEO through a multimillion-dollar sleight of hand.
By Ana Marie Cox
January/February 1998 Issue

So You Want To Trade With a Dictator
A step-by-step guide on how to get around foreign trade sanctions, human rights groups, and religious activists, and still have God on your side.
By Ken Silverstein
May/June 1998 Issue

Monsanto vs. the Milkman
A Maine dairy fights for the right to wear its hormone-free label.
By Susan Q. Stranahan
January/February 2004 Issue

A Cure for the Common Farm?
Genetically engineered 'pharmacrops' could be a curse for the Corn Belt -- or the family farm's last hope.
By Lucinda Fleeson
March/April 2003 Issue

Biotech's Black Market
An agricultural mystery in India has set off concerns over a growing underground trade in genetically engineered seeds.
By Douglas McGray
September/October 2002 Issue

Seeds of Secrecy The Mexican government has tried to silence scientists who discovered genetically modified corn where it doesn't belong.
By Kristi Coale
May/June 2002 Issue

Growing Resistance
Is agribusiness squandering one of medicine's most potent weapons?
By Edwin Dobb
November/December 2000 Issue

Same Great Taste? By George B. Sanchez
November/December 2001 Issue

A Biodefense Boondoggle
As pharmaceutical companies line up for multimillion-dollar contracts to make bioterrorism vaccines, some question whether the industry is up to the job.
By Bill Hogan
January/February 2002 Issue An Engineered Controversy
Farmers fear that genetically altered tobacco will contaminate their crops.
By Jane Akre
January/February 2002 Issue

People 2.0
Editor's Note
By Jeffrey Klein
May/June 1998 Issue

The New You: A Special Biotechnology Report
As corporations buy up stock in the human body, they also determine our future.
May/June 1998 Issue

An Owners' Guide
Pharmaceutical companies are mining your DNA for scientific gold.
By Hope Shand
May/June 1998 Issue

Patent Pending
Consumer-driven science and the new eugenics.
By Jeremy Rifkin
May/June 1998 Issue

Where New Genes Come From
By Hope Shand
May/June 1998 Issue

Next Year's Model
Imagining consumer-driven genetics.
By Ana Marie Cox and Kerry Lauerman
May/June 1998 Issue

Iceland's Blond Ambition
A Nordic country cashes in on its isolated gene pool.
By Eliot Marshall
May/June 1998 Issue

Regulating the Researchers
Does a ban on public funding mean a ban on public knowledge?
By Rachel Burstein
May/June 1998 Issue

A Growing Concern
As biotech crops come to market, neither scientists -- who take industry money -- nor federal regulators are adequately protecting consumers and farmers.
By Susan Benson, Mark Arax and Rachel Burstein
January/February 1997 Issue Flavor Saved?
Genetically engineered foods are in the supermarket now, and more are coming soon.
By Susan Benson and Leora Broydo
January/February 1997 Issue

No Way Around Roundup
Monsanto's bioengineered seeds are designed to require more of the company's herbicide.
By Mark Arax and Jeanne Brokaw
January/February 1997 Issue

Paid Protection
Why Monsanto and other industry giants love EPA regulations.
By Rachel Burstein
January/February 1997 Issue

Future Schlock
Forget the Jetsons. In our market-driven present, the future is only a focus group away.
By Jack Hitt
March/April 2001 Issue

Does It Pay to Subvertise? The critics of corporate propaganda co-opt its best weapon.
By G. Beato
May/June 1999 Issue

Give the People What They Don't Want
Rejecting the tyranny of the focus group
By G. Beato
March/April 1999 Issue

Bringing Things into Focus Even a lowly columnist can get in on the multibillion-dollar market research game By G. Beato
January/February 1999 Issue

Easy Money
Americans are betting more than $550 billion a year. With corporate ownership, a new mainstream image, and political clout, the gambling industry is on a roll.
By Martin Koughan
July/August 1997 Issue

All Bets Are Off
Although the gambling juggernaut marches on, citizens groups have effectively blocked its progress in several states.
By April Lynch
July/August 1997 Issue

Heavy Betting
Nation-wide gambling political contributions: a Mother Jones special investigation.
July/August 1997 Issue

World Wide Wagering
The internet already offers opportunities to lose your shirt without leaving your home -- and more gambling sites are on the way.
By Sandra Rosenzweig
July/August 1997 Issue

Crossing the Lines
How a top Pentagon official and a host of influential Republicans almost made sure that one American company gained a key stake in Iraq's lucrative wireless market.
By Michael Scherer
Additional reporting by David Enders and Jason Vest
September/October 2004 Issue

Contracts With America
Never before have private companies done so much of the government's work, from homeland security to rebuilding Iraq. So who's making sure the public gets its money's worth? Why, contractors, of course.
By Michael Scherer May/June 2004 Issue

Medicare's Hidden Bonanza
After millions in campaign contributions, an insurance magnate's 10-year lobbying campaign finally pays off.
By Michael Scherer
March/April 2004 Issue

Sidestepping Sanctions
While the Bush administration looks the other way, U.S. companies are dodging laws that bar them from doing business with nations accused of sponsoring terrorism.
By Michael Scherer
July/August 2003 Issue

Ghostwriting the Law
A little-known corporate lobby is drafting business-friendly bills for state legislators across the country.
By Karen Olsson
September/October 2002 Issue

Unjust Rewards
The government continues to award federal business worth billions to companies that repeatedly break the law. We reveal which major contractors are the worst offenders.
By Ken Silverstein
May/June 2002 Issue

Star-Spangled Lobbyists
Rushing to enlist in the war on terrorism, corporate lobbyists are doing their patriotic duty by seeking federal handouts for everything from bison meat to chauffeured limousines.
By Bill Hogan
March/April 2002 Issue

Still in Control
Alexander Haig seemed to slip off the global stage after his brief stint as Ronald Reagan's secretary of state. But in fact, he's still very much a player.
By Ken Silverstein
September/October 1999 Issue

10 Little Piggies
Forget welfare moms and the unemployed. No one feeds at the public trough like these ten.
By Dan Carney
July/August 1995 Issue

Shakedown
American folklore is rife with tall tales about lobbyists with bulging wallets who prowl the Capitol corridors buying legislators. But the truth is that it works mainly the other way.
By Martin Schram
September/October 1994 Issue

Bill's Delivery
When it comes out of our oven it's got something for everyone. We'll rush it to you, but first we gotta stop by Capitol Hill.
By Viveca Novak
November/December 1993 Issue

The Banker's Hour
Remember those "character loans the S&L scoundrels handed out to their friends? Now the banks want the same privilege--and effectively lobbied Clinton to get it.
By Stephen Pizzo
May/June 1993 Issue

Body Politic
Who has the president's ear? How much did they pay for it?
By L.J. Davis
March/April 1993 Issue

The Crude Doctrine
Azerbaijan would seem the perfect place to test President Bush's commitment to remaking the Muslim world. But its ruler has something that trumps democracyócontrol of billions of barrels of oil.
By David CaseM
July/August 2004 Issue

Over a Barrel
Experts say we're about to run out of oil. But we're nowhere near having another technology ready to take its place.
By Paul Roberts
November/December 2004 Issue

The Thirty-Year Itch
Three decades ago, in the throes of the energy crisis, Washington's hawks conceived of a strategy for US control of the Persian Gulf's oil. Now, the same strategists are firmly in control of the White House.
By Robert Dreyfuss
March/April 2003 Issue

The Valdez Crud
Are crude oil and chemicals to blame for the health problems of workers who cleaned up Exxon's mess?
By Susan Q. Stranahan
March/April 2003 Issue

Public Money in the Pipeline
When ExxonMobil and BP need millions to pay for their oil projects, who do they turn to? The U.S. government.
By Daphne Eviatar
January/February 2003 Issue

Nature vs. Natural Gas
To drill, or not to drill -- that's up to Mobil oil. By Catherine Elton
January/February 2000 Issue

Keeping the Coast Clear
How a band of activists blocked Big Oil's drilling plans off North Carolina's outer banks.
By Jan DeBlieu
September/October 2001 Issue

Counting Caribou
The Bush-Cheney oil drilling plan could endanger the Arctic's largest caribou herd -- and the people who depend on it.
By Tom Dunkel
May/June 2001 Issue

Texaco's Crude Legacy
It's the water. It's the sludge. It's the oil fires. It's the pits.
By Alex Markels
May/June 1999 Issue

Interview: Susana Almanza
Putting Big Oil in its place
By Jessica Shattuck
November/December 1998 Issue

Prosecuting for Pharma
Antidepressant manufacturers team up with district attorneys to make sure the Zoloft defense doesnít fly.
By Rob Waters
November/December 2004 Issue

Smuggling Hope
Her father was dying, and the drug company wanted $47,000 for his medication. So she did what any daughter would do: She became a liar and a fraud.
By Julia Whitty
March/April 2004 Issue

Is it Prozac? Or Placebo?
New research suggests that the miracles promised by antidepressants may be largely due to the placebo effect. Too bad there's no money to be made in sugar pills.
By Gary Greenberg
November/December 2003 Issue

Teen Herbicide
Dietary supplements can be deadly. So why are they being marketed to kids?
By Chris Mooney
May/June 2003 Issue

Disorders Made to Order
Pharmaceutical companies have come up with a new strategy to market their drugs: First go out and find a new mental illness, then push the pills to cure it.
By Brendan I. Koerner
July/August 2002 Issue

A Deadly Dearth of Drugs
While the pharmaceutical industry and the vice president played politics, South African AIDS patients paid with their lives.
By L.J. Davis
January/February 2000 Issue

Prime Time Pushers
Freed from federal restrictions, pharmaceutical companies are flooding television with ads for prescription drugs. What does it mean for our health care?
By Lisa Belkin
March/April 2001 Issue

Prescription for Controversy
Do corporate donations to the American Heart Association influence its drug guidelines?
By Jeanne Lenzer
May/June 2001 Issue

The Other Drug War
The FDA is wasting its time impeding harmless rice imports while ignoring what may be the fourth-leading cause of death.
By Michael Castleman
November/December 1998 Issue

Secondhand Diplomacy
After closed-door meetings with cigarette makers, the Bush administration is seeking to derail a global tobacco treaty.
By Barry Yeoman
March/April 2003 Issue

Up in Smoke
States promised to use the tobacco settlement to fight smoking -- but some are reinvesting the money in Big Tobacco.
By Michael Scherer
November/December 2002 Issue

Big Tobacco Rides East
With a squinting cowboy, cute cigarette girls, an American allure, and a poorly funded opposition.
By Robert Dreyfuss
January/February 1999 Issue

Tobacco Strikes Back
A MOTHER JONES INVESTIGATION
May/June 1996 Issue

Tobacco Dole
What do Bob Dole's telemarketer, his chief California strategist, and one of his national co-chairs have in common? Big Tobacco.
By Sheila Kaplan
May/June 1996 Issue

Our Good Friend, the Governor
GOP governors secretly help Big Tobacco.
By Peter H. Stone
May/June 1996 Issue

Tobacco Enemy Number One
Gingrich calls Kessler "a bully and a thug." Dole has pledged to fire him. When you look behind these attacks, says one top FDA official, "you will see the tobacco industry."
By Robert Dreyfuss
May/June 1996 Issue

The Nicotine Network
How Big Tobacco and Republican congressional leaders help each other gain power.
By Peter H. Stone
May/June 1996 Issue

Fakin' It
Inside "smoker's rights" groups--Big Tobacco's first effort to speak on behalf of the people.
By Ted Gup
May/June 1996 Issue

The War in the States
Tobacco's Current Strategy: Use state politicians to pre-empt local smoking controls.
By Jeanne Brokaw, Rachel Burstein, and Robert Dreyfuss
May/June 1996 Issue

Sin of Omission

How long can religious conservatives go on about protecting kids from dangerous drugs without saying anything about smoking?
By William Saletan
May/June 1996 Issue

Censored: The Leaked ABC Tape
A transcript and QuickTime video of "Tobacco Under Fire," the provocative TV documentary ABC chose not to let you see.
May/June 1996 Issue

A Life in Smoke
How cigarettes work on your body as they destroy it.
By Michael Castleman
May/June 1996 Issue